Abstract
The aging world population requires a sustainable and high-quality healthcare system. To examine the efficiency of medical cooperation, medical provider and physician networks were constructed using patient claims data. Previous studies have shown that these networks contain information on medical cooperation. However, the usage patterns of multiple medical providers in a series of medical services have not been considered. In addition, these studies used only general network features to represent medical cooperation, but their expressive ability was low. To overcome these limitations, we analyzed the medical provider network to examine its overall contribution to the quality of healthcare provided by cooperation between medical providers in a series of medical services. This study focused on: i) the method of feature extraction from the network, ii) incorporation of the usage pattern of medical providers, and iii) expressive ability of the statistical model. Femoral neck fractures were selected as the target disease. To build the medical provider networks, we analyzed the patient claims data from a single prefecture in Japan between January 1, 2014 and December 31, 2019. We considered four types of models: a model using node strength and linear regression to a model using feature representation by node2vec and regression tree ensemble, which is a machine learning method. The results showed that a stronger medical provider reduces the duration of hospital stay. The overall contribution of the medical cooperation to the duration of hospital stay extracted from the medical provider network using node2vec is approximately 20%, which is approximately 20 times higher than the model using strength.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JSPS KAKENHI (Grant Number: JP19H01075) from the Japan Society for the Promotion of Science and Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (Grant Number: 21IA1005 and 21FA1012). YO thanks the Kyoto University Science and Technology Innovation Creation Fellowship. Y. Ikeda and YO would also like to acknowledge Ripple, which is providing financial support through its University Blockchain Research Initiative.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Kyoto University Graduate School and Faculty of Medicine, Ethics Committee (approval number: R0439) and conducted in accordance with the Ethical Guidelines for Medical and Biological Research Involving Human Subjects established jointly by Japanese ministries. According to the guidelines, written informed consent was waived for this research as it did not utilize human biological specimens and any information utilized in the study has been anonymized.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* ohki.yu.65a{at}st.kyoto-u.ac.jp (YO), ikeda.yuichi.2w{at}kyoto-u.ac.jp (YI)
Data Availability
The data generated and analyzed during this study cannot be shared publicly, the Ethical Guidelines for Medical and Biological Research Involving Human Subjects established jointly by Japanese ministries. However, other researchers may send data access requests to Office of Research Promotion, General Affairs and Planning Division, Kyoto University (E-mail: 060kensui{at}mail2.adm.kyoto-u.ac.jp Tel: +81-75-753-9301).
